Back to Search
EYDIA S PEREZ, PHARMD
PHARMD
Pharmacist
NPI: 1073152385Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
6436(PR)
Research & Publications (20)
Surgical outcomes of gastrointestinal sarcoma including gastrointestinal stromal tumors: a population-based examination.
PMID 17390197·J Gastrointest Surg·2007
8-other
Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors.
PMID 16571433·J Am Coll Surg·2006
8-other
Impact of the host cadaver on survival and infectivity of entomopathogenic nematodes (Rhabditida: Steinernematidae and Heterorhabditidae) under desiccating conditions.
PMID 12623311·J Invertebr Pathol·2003
7-preclinical
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial.
PMID 19625343·Ann Oncol·2010
3-trial
Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualization.
PMID 19526354·Breast Cancer Res Treat·2010
8-other
Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based study.
PMID 19347979·J Thorac Oncol·2009
2-rct
Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways.
PMID 19101790·Breast Cancer Res Treat·2009
6-review
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC.
PMID 19214743·Breast Cancer Res Treat·2009
3-trial
Comprehensive diagnostic program for medically underserved women with abnormal breast screening evaluations in an urban population.
PMID 19339648·Mayo Clin Proc·2009
8-other
Impact of hospital volume on surgical outcome for head and neck cancer.
PMID 18982393·Ann Surg Oncol·2009
8-other
Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer.
PMID 18443902·Breast Cancer Res Treat·2009
6-review
Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336.
PMID 19047293·J Clin Oncol·2009
3-trial
Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer.
PMID 19075260·J Clin Oncol·2009
3-trial
Estrogen receptor beta as a mitochondrial vulnerability factor.
PMID 19189968·J Biol Chem·2009
7-preclinical
Rheological characterization of a new type of colloidal dispersion based on nanoparticles of gelled oil.
PMID 19621943·J Phys Chem B·2009
8-other
Progesterone modulation of alpha5 nAChR subunits influences anxiety-related behavior during estrus cycle.
PMID 19220484·Genes Brain Behav·2009
7-preclinical
Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response.
PMID 19261255·Lancet Oncol·2009
6-review
Treatment of metastatic breast cancer: looking towards the future.
PMID 18465221·Breast Cancer Res Treat·2009
6-review
Malignant pancreatic tumors: incidence and outcome in 58 pediatric patients.
PMID 19159743·J Pediatr Surg·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- CALLE 65 DE INFANTERIA #68
ANASCO, PR 00610 - Phone
- (787) 826-2390
Quick Facts
- NPI
- 1073152385
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile